Advertisement

Topics

Spectrum Pharma Highlights Results Of A Combination Study Of FOLOTYN (Pralatrexate Injection) Plus Romidepsin Presented At (14-ICML) Meeting

20:00 EDT 18 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Spectrum Pharma Highlights Results Of A Combination Study Of FOLOTYN (Pralatrexate Injection) Plus Romidepsin Presented At (14-ICML) Meeting

NEXT ARTICLE

More From BioPortfolio on "Spectrum Pharma Highlights Results Of A Combination Study Of FOLOTYN (Pralatrexate Injection) Plus Romidepsin Presented At (14-ICML) Meeting"

Advertisement
Quick Search
Advertisement
Advertisement